PL401166A1 - Zlozony sorbent jelitowy - Google Patents
Zlozony sorbent jelitowyInfo
- Publication number
- PL401166A1 PL401166A1 PL401166A PL40116612A PL401166A1 PL 401166 A1 PL401166 A1 PL 401166A1 PL 401166 A PL401166 A PL 401166A PL 40116612 A PL40116612 A PL 40116612A PL 401166 A1 PL401166 A1 PL 401166A1
- Authority
- PL
- Poland
- Prior art keywords
- intestinal
- group
- silicic acid
- sorbent composite
- sorbent
- Prior art date
Links
- 230000000968 intestinal effect Effects 0.000 title abstract 2
- 239000002594 sorbent Substances 0.000 title abstract 2
- 239000002131 composite material Substances 0.000 title 1
- FXSGDOZPBLGOIN-UHFFFAOYSA-N trihydroxy(methoxy)silane Chemical compound CO[Si](O)(O)O FXSGDOZPBLGOIN-UHFFFAOYSA-N 0.000 abstract 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract 1
- 229920001503 Glucan Polymers 0.000 abstract 1
- 229920001202 Inulin Polymers 0.000 abstract 1
- 229920000615 alginic acid Polymers 0.000 abstract 1
- 229960001126 alginic acid Drugs 0.000 abstract 1
- 235000010443 alginic acid Nutrition 0.000 abstract 1
- 239000000783 alginic acid Substances 0.000 abstract 1
- 150000004781 alginic acids Chemical class 0.000 abstract 1
- 239000000017 hydrogel Substances 0.000 abstract 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 1
- 229940029339 inulin Drugs 0.000 abstract 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 abstract 1
- 229960000511 lactulose Drugs 0.000 abstract 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 150000004804 polysaccharides Chemical class 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/732—Pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Biochemistry (AREA)
- Physiology (AREA)
- Toxicology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Zlozony sorbent jelitowy oparty na polimerze wybranym z grupy obejmujacej kserozel kwasu metylokrzemowego lub hydrozel kwasu metylokrzemowego zawiera przynajmniej jeden polisacharyd wybrany z grupy obejmujacej, laktuloze, inuline, lignine, fruktooligosacharydy, kwas alginowy w postaci soli akceptowanych farmaceutycznie, chitosan, pektyne, gume arabska beta-glukan.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201113802A UA103089C2 (ru) | 2011-11-23 | 2011-11-23 | Композиционный энтеросорбент на основе кремниевого полимера |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL401166A1 true PL401166A1 (pl) | 2013-05-27 |
Family
ID=48222154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL401166A PL401166A1 (pl) | 2011-11-23 | 2012-10-11 | Zlozony sorbent jelitowy |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20130129659A1 (pl) |
| CZ (1) | CZ308038B6 (pl) |
| DE (1) | DE102012109727A1 (pl) |
| PL (1) | PL401166A1 (pl) |
| UA (1) | UA103089C2 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2591791C2 (ru) * | 2014-09-30 | 2016-07-20 | Александр Владимирович Диковский | Композиция для детоксикации организма |
| UA112474C2 (uk) * | 2014-11-20 | 2016-09-12 | Юрій Захарович Толчеєв | Спосіб одержання пастоподібного сорбенту на основі гідрогелю метилкремнієвої кислоти |
| RU2612011C1 (ru) * | 2015-10-15 | 2017-03-01 | государственное бюджетное образовательное учреждение высшего профессионального образования "Пермский государственный медицинский университет имени академика Е.А. Вагнера" Министерства здравоохранения Российской Федерации | Энтеросорбент |
| CN113773989B (zh) * | 2021-08-30 | 2023-06-13 | 大连工业大学 | 植物乳杆菌y12所产胞外多糖在缓解由福氏志贺氏菌引起痢疾病症的应用 |
| WO2024205551A1 (ru) * | 2023-03-31 | 2024-10-03 | Вадим Алексеевич Козловский | Фармацевтическая композиция для энтеральной детоксикации и способ ее изготовления |
| WO2025155277A2 (en) * | 2024-01-17 | 2025-07-24 | Kozlovskyi Vadym Oleksiiovych | Composition and method of its production |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2048123C1 (ru) | 1991-12-10 | 1995-11-20 | Николай Николаевич Терещенко | Способ производства продукта для диетического питания |
| EP1306128A1 (en) * | 2001-10-29 | 2003-05-02 | Tenaxis Gmbh | Sorptive composite materials |
| UA54103A (uk) | 2002-05-14 | 2003-02-17 | Львівський Державний Медичний Університет Ім. Данила Галицького | Спосіб відновлення внутрішньокишкової флори у пацієнтів з гострим деструктивним панкреатитом в ранньому післяопераційному періоді |
| UA62152A (en) | 2002-12-29 | 2003-12-15 | Danylo Halytskyi Lviv State Ne | Method for decreasing volume of intestinal evacuations and restoring intestinal microflora in patients with ileostoma at early postoperative stage |
| UA82774C2 (uk) * | 2006-09-20 | 2008-05-12 | Tolcheiev Yurii Zakharovych | Спосіб одержання сорбенту на основі гідрогелю метилкремнієвої кислоти |
| PL2116564T3 (pl) * | 2007-02-09 | 2014-07-31 | Bioline Pharmaceutical Ag | Absorbent i sposób jego wytwarzania |
| UA24987U (en) | 2007-02-16 | 2007-07-25 | Kyiv Nat Univ Tech & Design | Drive of round-knitting machine |
| ITMI20071214A1 (it) * | 2007-06-15 | 2008-12-16 | S I I T Srl Servizio Internazi | Composizioni a base di componenti prebiotici ed immunogenici per la prevenzione e il trattamento di disturbi gastroenterici da disbiosi e/o alterazioni della normale flora intestinale |
| RU2433751C2 (ru) * | 2009-05-05 | 2011-11-20 | Александр Владимирович Диковский | Композиция для нормализации микрофлоры и очищения организма от токсинов и способ оздоровления организма |
| RU2455012C1 (ru) * | 2011-01-11 | 2012-07-10 | Учреждение Российской академии медицинских наук Научно-исследовательский институт медицинских проблем Севера Сибирского отделения РАМН | Способ энтеральной детоксикации при лечении иммунных нарушений |
| UA64357U (ru) * | 2011-03-16 | 2011-11-10 | Алєксандр Владіміровіч Діковскій | Композиция для очистки организма от токсинов и нормализации микрофлоры кишечника |
-
2011
- 2011-11-23 UA UAA201113802A patent/UA103089C2/ru unknown
-
2012
- 2012-09-12 US US13/611,661 patent/US20130129659A1/en not_active Abandoned
- 2012-10-11 PL PL401166A patent/PL401166A1/pl unknown
- 2012-10-12 DE DE102012109727A patent/DE102012109727A1/de active Pending
- 2012-10-16 CZ CZ2012706A patent/CZ308038B6/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UA103089C2 (ru) | 2013-09-10 |
| CZ308038B6 (cs) | 2019-11-13 |
| US20130129659A1 (en) | 2013-05-23 |
| DE102012109727A1 (de) | 2013-05-23 |
| CZ2012706A3 (cs) | 2013-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL401166A1 (pl) | Zlozony sorbent jelitowy | |
| BR112014028353A2 (pt) | método de separação de hemicelulose e celulose a partir de fontes de polissacarídeo. | |
| WO2014105984A3 (en) | Implementing consistency groups with virtual machines | |
| EP2693336A4 (en) | VIRTUAL MACHINE MANAGEMENT SYSTEM AND METHOD FOR MANAGING VIRTUAL MACHINES | |
| EP2676638A4 (en) | STENT FOR ABDOMINAL CAVITY SHUNT | |
| JP2012205928A5 (pl) | ||
| GB2501204B (en) | Method for virtual machine failover management and system supporting the same | |
| EP2687008A4 (en) | VARIABLE HEATING STRUCTURES, SYSTEMS AND METHOD THEREFOR | |
| MX391839B (es) | Oligosacaridos de leche humana para mejorar sintomas de estres. | |
| BR112017000345A2 (pt) | composições de oligossacarídeo e métodos para produção das mesmas | |
| EP2723430A4 (en) | PAP SYSTEM | |
| DK2877574T3 (da) | Alpha (1,2)-fucosyltransferaser egnet til anvendelse i fremstillingen af fucosylerede oligosaccharider | |
| EP2680807A4 (en) | EASY TRANSFER TRANSMISSION SYSTEM | |
| GB201719444D0 (en) | Resynchronizing to first storage system after failover to second storage system mirroring first storage system | |
| EP2609396A4 (en) | Machine navigation system having integrity checking | |
| TR201901968T4 (tr) | Yeni̇lenmi̇ş selüloz elyaf. | |
| BR112013006259A2 (pt) | implementação de protocolo de interconexão de percurso rápido através de uma interface pcie | |
| EP2694456A4 (en) | MULTI-PURPOSE Lignin-CARBOHYDRATE BINDING SYSTEM | |
| HUE036511T2 (hu) | Eljárás pirferint tartalmazó, nyújtott leadású tabletta formájában lévõ gyógyászati készítmény elõállítására, és a készítmény alkalmazása krónikus veseelégtelenség, mell tokzsugorodás, és májfibrózis visszaszorítására embernél | |
| WO2012095301A3 (de) | Dialyseversorungssystem | |
| EP2904144A4 (en) | PROCESS FOR THE PRODUCTION OF PULP, SUGAR AND BY-PRODUCTS THEREOF FROM LIGNOCELLULOSE BIOMASS | |
| FI20126341L (fi) | Menetelmä mikrofibrilloidun selluloosan valmistamiseksi, josta vesi on poistettu | |
| SG11201402354YA (en) | Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease | |
| EP2765208A4 (en) | Palladium disulphide, process for its preparation and use | |
| EP2583691A4 (en) | MEANS FOR THE TREATMENT OF KIDNEY FIBROSIS |